LEXINGTON, Mass.--(BUSINESS WIRE)--N-of-One, the leading provider of molecular interpretation and therapeutic strategies for precision medicine for oncology, presented data suggesting that up to 50% of BRAF gene mutations can be found in locations other than the most common location, codon V600. In addition, though BRAF is most common in melanoma, N-of-One reported on BRAF mutations in others cancers as well, including lung, colorectal and thyroid cancers. N-of-One presented the data in a poster presentation at the Advances in Genome Biology and Technology (AGBT) meeting, held February 12-15, 2014 in Marco Island, Florida.
Help employers find you! Check out all the jobs and post your resume.
